Nanoform Finland (STU:4YL) Short Interest


STU:4YL Nanoform Finland PLC STU:4YL
68 GF Score
Price €0.77
GF Value €1.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nanoform Finland Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:4YL vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Nanoform Finland's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's Short Interest distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's Short Interest falls into.


STU:4YL
68GF Score
Nanoform Finland PLC STU:4YL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.77 is trading 56.3% below its estimated GF Value™ of €1.77. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

  • Short Interest:
  • GF Value™: €1.77 vs. price of €0.77 (56.3% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
68GF Score

Get the complete analysis for STU:4YL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price
€1.77
GF Value